Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Kamel Laribi

14PUBLICATIONS

35CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene and molecular therapyPredictive and prognostic markersImmunogenetics (incl. genetic immunology)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Apr 15, 2026

Factors influencing front line treatment of chronic lymphocytic leukemia: A French real-world study.

Arthur Coste, Nanthara Sritharan, Anne Lok

|Jul 12, 2025

Impact of Body Composition on Treatment Toxicity and Outcomes in Patients With Primary Mediastinal Large B-Cell Lymphoma.

Juliette Penichoux, Pierre Decazes, Cédric Rossi

|Mar 20, 2024

Long-term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO).

Kamel Laribi, Stéphanie Poulain, Lise Willems

|Dec 09, 2022

Retrospective, real-life study of venetoclax plus azacitidine or low-dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy.

Louise Laloi, Natacha Chaumard Billotey, Pierre-Yves Dumas

|Jul 05, 2022

Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study.

Nadia Younan, Carole Soussain, Sylvain Choquet

|Apr 19, 2022

A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations.

Lionel Adès, Nicolas Duployez, Agnes Guerci-Bresler

Pageof 3

Frequent Collaborators

2 joint publications

Pierre Fenaux

2 joint publications

Pierre Morel

2 joint publications

Damien Roos-Weil

2 joint publications

Eric Durot

2 joint publications

Lucie Oberic

1 joint publications

Emmanuel Gyan

1 joint publications

Morgane Nudel

1 joint publications

Pascale Cony-Makhoul

1 joint publications

Vincent Jachiet

1 joint publications

Thierry Guillaume

Frequent Collaborators

2 joint publications

Pierre Fenaux

2 joint publications

Pierre Morel

2 joint publications

Damien Roos-Weil

2 joint publications

Eric Durot

Top Related Videos

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on : Nov 26, 2018

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on : Nov 21, 2018

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on : Oct 17, 2025

See more related videos

Top Related Videos

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on : Nov 26, 2018

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on : Nov 21, 2018

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on : Oct 17, 2025

See more related videos